Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $123M | Buy |
1,830,235
+105,768
| +6% | +$7.05M | 0.03% | 366 |
|
|
2026
Q1 | $108M | Sell |
1,724,467
-2,907,804
| -63% | -$202M | 0.03% | 377 |
|
|
2025
Q4 | $307M | Sell |
4,632,271
-1,711,205
| -27% | -$111M | 0.08% | 196 |
|
|
2025
Q3 | $427M | Sell |
6,343,476
-1,225,414
| -16% | -$97M | 0.11% | 153 |
|
|
2025
Q2 | $661M | Sell |
7,568,890
-556,646
| -7% | -$43.6M | 0.18% | 98 |
|
|
2025
Q1 | $555M | Sell |
8,125,536
-12,986
| -0.2% | -$1.06M | 0.17% | 117 |
|
|
2024
Q4 | $633M | Buy |
8,138,522
+52,040
| +0.6% | +$3.85M | 0.18% | 97 |
|
|
2024
Q3 | $542M | Buy |
8,086,482
+1,646,145
| +26% | +$135M | 0.15% | 121 |
|
|
2024
Q2 | $730M | Sell |
6,440,337
-817,204
| -11% | -$103M | 0.21% | 90 |
|
|
2024
Q1 | $1.01B | Sell |
7,257,541
-234,751
| -3% | -$29.5M | 0.3% | 64 |
|
|
2023
Q4 | $931M | Sell |
7,492,292
-257,773
| -3% | -$26.3M | 0.3% | 69 |
|
|
2023
Q3 | $723M | Sell |
7,750,065
-184,085
| -2% | -$20.8M | 0.25% | 90 |
|
|
2023
Q2 | $1.02B | Buy |
7,934,150
+76,228
| +1% | +$9.22M | 0.35% | 58 |
|
|
2023
Q1 | $913M | Buy |
7,857,922
+141,952
| +2% | +$15.9M | 0.34% | 67 |
|
|
2022
Q4 | $874M | Sell |
7,715,970
-804,687
| -9% | -$88.3M | 0.34% | 70 |
|
|
2022
Q3 | $686M | Buy |
8,520,657
+230,774
| +3% | +$19.5M | 0.28% | 81 |
|
|
2022
Q2 | $618M | Sell |
8,289,883
-503,413
| -6% | -$45.9M | 0.24% | 90 |
|
|
2022
Q1 | $1.01B | Buy |
8,793,296
+595,028
| +7% | +$65.1M | 0.33% | 58 |
|
|
2021
Q4 | $1.1B | Sell |
8,198,268
-182,836
| -2% | -$26.3M | 0.33% | 59 |
|
|
2021
Q3 | $1.15B | Buy |
8,381,104
+1,059,408
| +14% | +$134M | 0.35% | 51 |
|
|
2021
Q2 | $782M | Buy |
7,321,696
+2,168,280
| +42% | +$208M | 0.23% | 93 |
|
|
2021
Q1 | $463M | Buy |
5,153,416
+797,532
| +18% | +$74.9M | 0.15% | 135 |
|
|
2020
Q4 | $403M | Buy |
4,355,884
+1,142,732
| +36% | +$102M | 0.14% | 140 |
|
|
2020
Q3 | $331M | Buy |
3,213,152
+259,004
| +9% | +$27.1M | 0.13% | 150 |
|
|
2020
Q2 | $299M | Sell |
2,954,148
-986,396
| -25% | -$88.2M | 0.12% | 161 |
|
|
2020
Q1 | $265M | Sell |
3,940,544
-35,644
| -0.9% | -$2.22M | 0.13% | 157 |
|
|
2019
Q4 | $217M | Sell |
3,976,188
-191,020
| -5% | -$9.06M | 0.08% | 235 |
|
|
2019
Q3 | $155M | Sell |
4,167,208
-263,732
| -6% | -$10.2M | 0.06% | 296 |
|
|
2019
Q2 | $166M | Buy |
4,430,940
+4,195,420
| +1,781% | +$132M | 0.07% | 301 |
|
|
2019
Q1 | $7.01M | Buy |
235,520
+72,144
| +44% | +$2.54M | 0.04% | 465 |
|
|
2018
Q4 | $4.89M | Sell |
163,376
-25,296
| -13% | -$802K | 0.03% | 489 |
|
|
2018
Q3 | $6.75M | Buy |
+188,672
| New | +$5.85M | 0.04% | 484 |
|
|
2017
Q4 | – | Sell |
-501,132
| Closed | -$6.13M | – | 1100 |
|
|
2017
Q3 | $6.13M | Sell |
501,132
-22,016
| -4% | -$389K | 0.04% | 461 |
|
|
2017
Q2 | $9.57M | Sell |
523,148
-88,072
| -14% | -$1.63M | 0.06% | 417 |
|
|
2017
Q1 | $12.9M | Buy |
611,220
+317,524
| +108% | +$6.2M | 0.08% | 354 |
|
|
2016
Q4 | $4.38M | Sell |
293,696
-277,912
| -49% | -$4.92M | 0.02% | 646 |
|
|
2016
Q3 | $12.5M | Sell |
571,608
-154,592
| -21% | -$3.44M | 0.07% | 322 |
|
|
2016
Q2 | $14.4M | Buy |
726,200
+645,824
| +804% | +$11M | 0.09% | 279 |
|
|
2016
Q1 | $1.36M | Sell |
80,376
-740,588
| -90% | -$12.4M | 0.01% | 902 |
|
|
2015
Q4 | $16.8M | Sell |
820,964
-66,608
| -8% | -$1.39M | 0.09% | 244 |
|
|
2015
Q3 | $19.1M | Buy |
887,572
+70,496
| +9% | +$1.57M | 0.11% | 228 |
|
|
2015
Q2 | $16.3M | Sell |
817,076
-238,800
| -23% | -$4.19M | 0.09% | 280 |
|
|
2015
Q1 | $16.5M | Buy |
1,055,876
+1,032,632
| +4,443% | +$15.6M | 0.09% | 297 |
|
|
2014
Q4 | $320K | Sell |
23,244
-908
| -4% | -$11.1K | ﹤0.01% | 1457 |
|
|
2014
Q3 | $241K | Buy |
24,152
+584
| +2% | +$5.97K | ﹤0.01% | 1482 |
|
|
2014
Q2 | $234K | Hold |
23,568
| – | – | ﹤0.01% | 1502 |
|
|
2014
Q1 | $244K | Hold |
23,568
| – | – | ﹤0.01% | 1474 |
|
|
2013
Q4 | $209K | Buy |
+23,568
| New | +$187K | ﹤0.01% | 1478 |
|
Other funds holding DXCM
Nuveen's DXCM Position: Q2 2026 in Review
Nuveen increased its DexCom (DXCM) stake by 6.1% in Q2 2026, buying an estimated $7.05M and bringing the position to 1,830,235 shares worth $123M. The position accounts for 0.03% of the portfolio, ranked #366.
Nuveen first reported a position in DXCM in Q4 2013 and has held it in 48 quarters since. The position peaked at $1.15B in Q3 2021. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Nuveen held 1,830,235 shares of DexCom worth $123M as of Q2 2026.
- Nuveen bought 105,768 DexCom shares in Q2 2026, an estimated $7.05M.
- DexCom made up 0.03% of Nuveen's portfolio in Q2 2026, its #366 holding.
- Nuveen first reported a position in DexCom in Q4 2013 and has held it in 48 quarters since.
- Nuveen's DexCom position peaked at $1.15B in Q3 2021.
- 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.